Alberta CANVAS-COVID
ACHIEVE Research
The Alberta Children’s Hospital Infectious Diseases, Epidemiology and Vaccine Evaluation (ACHIEVE) Research Team studies vaccine preventable infections, particularly in children, vaccine clinical trials, and vaccine evaluation projects.
The ACHIEVE Research Team is affiliated with the University of Calgary, Alberta Health Services (Calgary Zone) and the Alberta Children’s Hospital Research Institute (ACHRI).
Study Team
Co-Investigator
Dr. Otto G. Vanderkooi, MD FRCPC DTMH
Investigator, Alberta Children’s Hospital, University of Calgary & Alberta Health Services
Section Chief, Pediatric Infectious Diseases, Alberta Children’s Hospital
Associate Professor, Departments of Pediatrics, Pathology and Laboratory Medicine, Microbiology and Infectious Diseases (MID) and Community Health Sciences, University of Calgary
Dr. Vanderkooi is a Child Health and Wellness researcher at the Alberta Children’s Hospital Research Institute (ACHRI) and co-principal investigator of the ACHIEVE Research Team. Dr. Vanderkooi’s research is primarily in vaccine preventable diseases, vaccine clinical trials and vaccine safety. He has been the Calgary Site principal investigator for multiple studies with the Canadian Immunization Research Network including several clinical trials as well as the Canadian National Vaccine Safety (CANVAS) Network.
Co-Investigator
Investigator, Alberta Children’s Hospital, University of Calgary & Alberta Health Services
Clinician Primary Researcher, Alberta Children’s Hospital, Calgary
Professor, Departments of Pediatrics; Community Health Sciences; Microbiology, Immunology & Infectious Diseases, University of Calgary
After a decade as Department Head of Pediatrics in Calgary (2008-2018), Dr. Kellner has returned to his focus on his scholarly interest in vaccine preventable infections through research and advisory work. He leads or contributes to several local and national research groups. He is a member of the federal COVID-19 Immunity Task Force Leadership Group (www.covid19immunitytaskforce.ca) and Co-Chair of the Task Force’s Field Studies Working Party. Dr. Kellner is leading the multi-faceted Alberta Childhood COVID-19 Cohort (AB3C) Study (www.ucalgary.ca/covidinkids). The AB3C Study has enrolled over 1000 Calgary children who will be tested longitudinally for COVID-19 immunity over two years. The AB3C study is also conducting detailed genetic and immunity testing of COVID-19 infected children.
Site Coordinator
ACHIEVE Research Manager, Alberta Children’s Hospital, University of Calgary & Alberta Health Services
In her role with the ACHIEVE Research Team, Joslyn has managed multiple clinical trials, vaccine evaluation, and epidemiology studies. She coordinates the planning and conduct of numerous single-centre and multi-centre clinical research studies and clinical trials. Under Joslyn’s leadership, over the past decade more than 40,000 people have been enrolled into Alberta’s CANVAS surveillance program.
Website: ACHIEVE Research
Contact ACHIEVE: achieveresearch@canvas-covid.ca
